tbuckley/cabot-search huggingface dataset:
Surgeon General's Report on Acquired Immune Deficiency Syndrome
Journal: JAMA (1986)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
What is a health care trial?
Authors: W. O. Spitzer
Journal: JAMA (1975)

ALTHOUGH most people know what to expect as topics of the research conducted in such domains as biochemistry, microbiology, or epidemiology, the domain of health care research has not been clearly delineated. It sometimes seems to include a chaotic variety of activities, ranging from polemic debates about medical ethics to quantitative accounts of hospital finances to biostatistical experiments with randomized therapy. The heterogeneous components and varieties of such research create special problems for peer review committees and for administrators of agencies that support health care research. Because the distinctive features of the research have not been precisely demarcated, it is often difficult to reach a consensus about the merit or even the eligibility of projects under consideration. To help clarify some of the confusion, we have written this article for the taxonomic purpose of defining and classifying the kinds of investigation that constitute health care research. Health care research is
Pleural Effusion
Authors: Carol Barrett
Journal: JAMA (2017)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Authors' reply
Authors: Samuel C. L. Lo, Michael J. Oldmeadow, Margaret A. Howard
Journal: American Journal of Hematology (1989)

We are interested to learn that Rosove et al. have now changed the criteria for the interpretation of the results of their StdiHigh PC-APTT test [ 11.As they say, had we considered the 8 "indeterminate" results in our study [2] positive, then 18/18 plasmas would have been positive by this test.Not only that, all 4 of the warfarin control patients would now be classified as positive using the new criteria (compared to the previously reported 3/41
Biliary Sludge
Authors: C W Ko, J H Sekijima, S P Lee
Journal: Annals of Internal Medicine (1999)

Biliary sludge was first described with the advent of ultrasonography in the 1970s. It is defined as a mixture of particulate matter and bile that occurs when solutes in bile precipitate. Its composition varies, but cholesterol monohydrate crystals, calcium bilirubinate, and other calcium salts are the most common components. The clinical course of biliary sludge varies, and complete resolution, a waxing and waning course, and progression to gallstones are all possible outcomes. Biliary sludge may cause complications, including biliary colic, acute pancreatitis, and acute cholecystitis. Clinical conditions and events associated with the formation of biliary sludge include rapid weight loss, pregnancy, ceftriaxone therapy, octreotide therapy, and bone marrow or solid organ transplantation. Sludge may be diagnosed on ultrasonography or bile microscopy, and the optimal diagnostic method depends on the clinical setting. This paper proposes a protocol for the microscopic diagnosis of sludge. There are no proven methods for the prevention of sludge formation, even in high-risk patients, and patients should not be routinely monitored for the development of sludge. Asymptomatic patients with sludge can be managed expectantly. If patients with sludge develop symptoms or complications, cholecystectomy should be considered as the definitive therapy. Further studies of the pathogenesis, natural history, and clinical associations of biliary sludge will be essential to our understanding of gallstones and other biliary tract abnormalities.
Section 12.—Amyloidosis
Journal: JAMA (1973)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Howard Bancroft Andervont 1898–1981
Journal: JNCI Journal of the National Cancer Institute (1981)

Journal Article Howard Bancroft Andervont 1898–1981 Get access JNCI: Journal of the National Cancer Institute, Volume 67, Issue 1, July 1981, Page 1, https://doi.org/10.1093/jnci/67.1.1 Published: 01 July 1981
Essays in Pastoral Medicine.
Journal: JAMA (1907)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The toxicity gap: Do real-life patients get hospitalized more during chemotherapy compared to trial patients?
Authors: Rebecca Michelle Prince, Monika K Krzyzanowska, Eshetu G. Atenafu
Journal: Journal of Clinical Oncology (2014)

6519 Background: Toxicity related hospitalizations during chemotherapy are poorly reported in the literature. We sought to compare “real world” versus clinical trial rates of hospitalizations among patients with metastatic non-small cell lung cancer (mNSCLC) receiving chemotherapy. We hypothesised that hospitalization rates in real life patients would be significantly higher. Methods: We conducted a systematic review of Medline and EMBASE (1946-June 2013) to identify articles reporting hospitalization rates during chemotherapy in patients with cancer. Both observational studies and clinical trials were eligible. This report focuses on patients with mNSCLC receiving palliative chemotherapy as data was available for this clinical scenario in both the observational and clinical trial setting, allowing comparison. Study results were abstracted using a standardised form. Summary statistics were used to describe results and the chi-square test used to compare hospitalization rates. Results: The search identified 64 articles (all published after 1987), of which 19 were clinical trials and 45 were observational (“real world”) studies. Nine studies examined chemotherapy in mNSCLC - four observational studies and five randomised trials. The four observational studies included 7,456 patients; three included patients on any chemotherapy while the other focused on doublet regimens. Of the five randomised trials which included 3,556 patients, three treated patients with platinum doublets and two used single agent chemotherapy. The real life cohort was older (69.2 years vs. 62 years). The aggregate hospitalization rate among real life patients was significantly higher than among trial patients (57.5% vs. 14.8%, OR=7.7, 95% CI 6.9-8.5, p-value < 0.0001). Performance status and type of chemotherapy were associated with hospitalization during chemotherapy in clinical trials. The observational studies did not report risk factors for hospitalization. Conclusions: Clinical trials in mNSCLC consistently report lower rates of hospitalization than real life cohorts of patients undergoing similar therapies but very few clinical trials report this information.
<i>Jahresbericht der Niederæsterreichischen Landesirrenanstalten Wien, Ybbs, Klosternenberg und des Irrenanstaltfiliales Gugging-Kierling pro 1888.</i> (Annual Report of the Lower Austrian Public Asylums for the Insane at Vienna, Ybbs, Klosternenberg, and the Branch Asylum at Gugging-Kierling, for 1888.)
Journal: American Journal of Psychiatry (1890)
An Elementary Atlas of Cardiography: An Introduction to Electrocardiography and X-Ray Examination of the Heart
Journal: JAMA (1949)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Subscription Information
Authors: Patricia Morrissey, Christine Burgos-Clavel
Journal: Kidney International (2021)

Kidney International is devoted to kidney research.It aims to inform the researcher, the clinical investigator, and the practicing nephrologist on all aspects of kidney research.These include the latest clinical studies on emerging developments in nephrology and the highest level of original research studies in clinical and basic kidney research.The journal reflects the field through critical reviews, commentaries, original articles, remarkable images, news features, guidelines, and problem-focused articles for the diagnosis and treatment of kidney patients.
Dietary Calcium Intakes of Urban Children at Risk of Lead Poisoning
Authors: Kay Bruening, Francis W. Kemp, Nicole Simone, Yvette Holding, Donald B. Louria, John D. Bogden
Journal: Environmental Health Perspectives (1999)

Dietary calcium is well known to decrease gastrointestinal lead absorption and thereby reduce the risk for lead poisoning. Because children in economically deprived urban centers are especially likely to have excessive lead exposure, we surveyed dietary calcium intakes of 314 children from the greater Newark, New Jersey, area. The areas of Newark and adjacent communities studied had been previously identified as containing significant sources of environmental lead by geographic information systems technology. An abbreviated National Cancer Institute Health Habits and History Questionnaire, modified to focus on foods high in calcium, was used to determine dietary calcium. Calcium intakes were then compared to the new Dietary Reference Intake (DRI) guidelines. The respondents were primarily the parents of African-American and Hispanic children ranging in age from 1 to 8 years, with a mean age of 3.5 years. The most recent blood lead concentration was 11.4 +/- 0.8 microg/dL (mean +/- standard error), and 48.6% had concentrations at or above the current guideline of 10 microg/dL. Quintiles of calcium intake were: 221 +/- 13; 488 +/- 9; 720 +/- 6; 885 +/- 6; and 1,389 +/- 49 mg/day. Fifty-five of 175 (31.4%) children aged 1-3 years had calcium intakes below the DRI, as did 82 of 139 (59.0%) children aged 4-8 years. The percentage of mothers reporting lactose intolerance in their children was 2.5%. The observation that the children in the highest quintile easily exceeded the DRIs for calcium suggests that urban parents who include dairy foods in their childrens' meals can provide a diet that meets the DRI guidelines. Children in the lowest quintiles are at risk of increased absorption of the environmental lead to which they are inevitably exposed, as well as other problems associated with a low intake of dietary calcium. The data suggest that both lead exposure and low dietary calcium continue to pose significant health risks to urban minority children.
P35.22 WITHDRAWN
Authors: L Wang, X Liu, X Yu, Z Zhao, Y Zhang, Y Bai, S Zhang, Y Xu, P Zhao, H Bao, X Wang, R Liu, R Xu, J Xiang, H Jiang, J Yan, X Wu, Y Shao, J Liang, Q Wu, Z Zhang, S Lu, S Ma
Journal: Journal of Thoracic Oncology (2021)
Evolution of Elastic Configuration of Pulmonary Trunk in People Native to High Altitudes
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
THE MICROBE AS A FACTOR IN EVOLUTION.
Journal: JAMA (1896)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Nicotine Dependence
Authors: Naomi Breslau
Journal: JAMA (1994)

<h3>To the Editor.</h3> —In their review of addiction medicine, Drs Franklin and Frances<sup>1</sup>highlight recent research on nicotine addiction. Clearly, information on why people smoke is needed if public health efforts to improve the health of the nation are to succeed. Several studies are cited, among them, our prospective study on the association between nicotine dependence and major depression in young adults.<sup>2</sup>In the<i>JAMA</i>review, the association between nicotine dependence and major depression in women is emphasized. However, the association we observed was in both women and men. We reported a more than twofold risk for major depression in persons with a history of nicotine dependence (odds ratio, 2.45; 95% confidence interval [CI], 1.17 to 5.15), and because there was not a sex difference, we did not present sex-specific findings. To prevent any misunderstanding on this point, we summarize here our findings in women and men separately.
BREAKFASTLESS SCHOOL CHILDREN.
Journal: JAMA (2008)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Endometrial Carcinoma
Authors: P G Rose
Journal: New England Journal of Medicine (1996)

Uterine cancer is the fourth most frequent cancer in women, with an estimated 34,000 cases and 6000 deaths in the United States in 1996.1 It is the most curable of the 10 most common cancers in women and the most frequent and curable of the gynecologic cancers. Ninety-seven percent of all cancers of the uterus arise from the glands of the endometrium and are known as endometrial carcinomas. The remaining 3 percent of uterine cancers are sarcomas, which are not discussed here. Numerous changes in the pathological description of endometrial cancer, identification of prognostic variables, staging, and treatment have occurred . . .
White House aide studying AIDS Commission recommendations; reports to President soon
Authors: C. Marwick
Journal: JAMA (1988)

PRESIDENT RONALD REAGAN says the final report of his Commission on the Human Immunodeficiency Virus (HIV) Epidemic is an impressive effort that "significantly increases our level of understanding to deal with acquired immunodeficiency syndrome." He is directing Donald Ian Macdonald, MD, the White House's special assistant for drug policy, to review the more than 600 recommendations (<i>JAMA</i>1988;260:16-17,<i>JAMA</i>1988;259:169-170, and<i>JAMA</i>1988;259:2195, 2199) and chart a future course of action to deal with the epidemic. This is an acknowledgment of a major message of the report, that control of the spread of the virus is related to drug abuse. Macdonald, previously administrator, Alcohol, Drug Abuse, and Mental Health Administration (<i>JAMA</i>1988;260:459), is to report back to the President in the next few days. <h3>Against Discrimination</h3> Another major, and more contentious, recommendation by the commission involves broadening and extending (to the private sector) the antidiscrimination provisions of the 1973 Rehabilitation
Immunological Diseases
Authors: Paul P. Van Arsdel
Journal: JAMA (1989)

With each passing decade immunologic phenomena and their roles in medicine are being recognized and characterized at a rate that seems to be accelerating without limits. It hardly needs to be said again that they are involved in the pathogenesis, diagnosis, and management of all aspects of medicine, in a spectrum extending from immune deficiencies through normal homeostasis to hypersensitivity. Accordingly, one can envision a treatise on the immunologic aspects of disease as being practically unlimited in scope. The task of designing and generating such a work within reasonable limits was formidable enough when the first edition of<i>Immunological Diseases</i>was published in 1965. How much more challenging the task must be today! That four editions have now been published is convincing evidence for the success of this work in coping with such formidable challenges. The latest edition is the product of over 6 years of effort by numerous people,